These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6420514)

  • 1. Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone.
    Andén NE; Grabowska-Andén M; Liljenberg B
    J Neural Transm; 1983; 58(3-4):143-52. PubMed ID: 6420514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the presence of autoreceptors on dopamine neurons in different brain regions.
    Andén NE; Grabowska-Andén M; Liljenberg B
    J Neural Transm; 1983; 57(3):129-37. PubMed ID: 6139410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of synthesis-modulating nerve terminal autoreceptors on mesoamygdaloid and other mesolimbic dopamine neuronal populations.
    Kilts CD; Anderson CM; Ely TD; Nishita JK
    J Neurosci; 1987 Dec; 7(12):3961-75. PubMed ID: 3121804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supersensitivity of dopamine-autoreceptors. The effect of gammabutyrolactone in long-term haloperidol treated rats.
    Stock G; Steinbrenner J; Kummer P
    J Neural Transm; 1980; 47(2):145-51. PubMed ID: 7373289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
    Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
    Barton AC; Moore KE; Demarest KT
    J Neural Transm; 1987; 68(1-2):25-39. PubMed ID: 2879883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
    Scalzo FM; Spear LP
    Psychopharmacology (Berl); 1985; 85(3):271-6. PubMed ID: 3923514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis rate of dopamine: difference between corpus striatum and limbic system as a possible explanation of variations in reactions to drugs.
    Andén NE; Grabowska-Andén M; Lindgren S; Thornström U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):193-8. PubMed ID: 6621714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic prenatal haloperidol exposure: lack of effect on presynaptic dopamine autoreceptors.
    Scalzo FM; Newport GD; Gough BJ; Ali SF; Holson RR
    Neurotoxicology; 1989; 10(3):485-90. PubMed ID: 2516618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.
    Andén NE; Nilsson H; Ros E; Thornström U
    Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):51-6. PubMed ID: 6301216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.
    Kehr W; Speckenbach W; Zimmermann R
    J Neural Transm; 1977; 40(2):129-47. PubMed ID: 323421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O; Mohringe B; Fowler CJ
    J Neural Transm; 1987; 69(3-4):163-77. PubMed ID: 2957465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of dopamine synthesis in mesolimbic dopamine neurons by immobilization stress in the rat.
    Watanabe H
    Neuropharmacology; 1984 Nov; 23(11):1335-8. PubMed ID: 6441893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.
    Carey RJ
    Biol Psychiatry; 1986 Mar; 21(3):317-21. PubMed ID: 3081055
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D; Salah RS; Galloway MP
    Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release.
    Chrapusta SJ; Karoum F; Egan MF; Wyatt RJ
    Eur J Pharmacol; 1993 Mar; 233(1):135-42. PubMed ID: 8472742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
    van Oene JC; de Vries JB; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):304-11. PubMed ID: 6514014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.